Good news_老虎社区_美港股上老虎

2021-08-23

Good news

Pfizer and BioNTech SE shares surged in premarket trading<blockquote>辉瑞和 BioNTech SE 股价在盘前交易中飙升</blockquote>

免责声明：上述内容仅代表发帖人个人观点，不构成本平台的任何投资建议。

精彩评论

我们需要你的真知灼见来填补这片空白

发表看法

{"i18n":{"language":"zh_CN"},"detailType":1,"isChannel":false,"data":{"magic":2,"id":835635214,"tweetId":"835635214","gmtCreate":1629709832838,"gmtModify":1633683030053,"author":{"id":4088757684331200,"idStr":"4088757684331200","authorId":4088757684331200,"authorIdStr":"4088757684331200","name":"CKF68","avatar":"https://static.tigerbbs.com/0fd6cab827059eec333bac6fa0dfde42","vip":1,"userType":1,"introduction":"","boolIsFan":false,"boolIsHead":false,"crmLevel":12,"crmLevelSwitch":0,"individualDisplayBadges":[],"wearingBadges":[],"fanSize":9,"starInvestorFlag":false},"themes":[],"images":[],"coverImages":[],"title":"","extraTitle":"","html":"<html><head></head><body>Good news</body></html>","htmlText":"<html><head></head><body>Good news</body></html>","text":"Good news","highlighted":1,"essential":1,"paper":1,"likeSize":1,"commentSize":0,"repostSize":0,"favoriteSize":0,"link":"https://laohu8.com/post/835635214","repostId":1104804215,"repostType":4,"repost":{"id":"1104804215","kind":"news","weMediaInfo":{"introduction":"Providing stock market headlines, business news, financials and earnings ","home_visible":1,"media_name":"Tiger Newspress","id":"1079075236","head_image":"https://static.tigerbbs.com/8274c5b9d4c2852bfb1c4d6ce16c68ba"},"pubTimestamp":1629706373,"share":"https://www.laohunote.com/m/news/1104804215?lang=zh_CN&edition=full","pubTime":"2021-08-23 16:12","market":"us","language":"en","title":"Pfizer and BioNTech SE shares surged in premarket trading<blockquote>辉瑞和 BioNTech SE 股价在盘前交易中飙升</blockquote>","url":"https://stock-news.laohu8.com/highlight/detail?id=1104804215","media":"Tiger Newspress","summary":"Pfizer and BioNTech SE shares surged in premarket trading.The F.D.A. is aiming to give full approval","content":"Pfizer and BioNTech SE shares surged in premarket trading.The F.D.A. is aiming to give full approval to Pfizer’s Covid vaccine on Monday,according to the New York Times.<blockquote>辉瑞和 BioNTech SE 股价在盘前交易中飙升。F.D.A。据《纽约时报》报道，辉瑞公司的目标是在周一全面批准辉瑞公司的 Covid 疫苗。</blockquote> <img src=\"https://static.tigerbbs.com/7fdc37e9193346a16038693153dd045e\" tg-width=\"362\" tg-height=\"125\" width=\"100%\" height=\"auto\"><blockquote></blockquote> The Food and Drug Administration is pushing to approve Pfizer-BioNTech’s two-dose Covid-19 vaccine on Monday, further expediting an earlier timeline for licensing the shot, according to people familiar with the agency’s planning.<blockquote>据熟悉美国食品和药物管理局计划的人士透露，美国食品和药物管理局正在推动在周一批准辉瑞-BioNTech公司的两剂Covid-19疫苗，进一步加快了疫苗许可的早期时间表。</blockquote> Regulators were working to finish the process by Friday but were still working through a substantial amount of paperwork and negotiation with the company. The people familiar with the planning, who were not authorized to speak publicly about it, cautioned that the approval might slide beyond Monday if some components of the review need more time.<blockquote>监管机构正在努力在周五之前完成这一流程，但仍在与该公司进行大量的文书工作和谈判。熟悉该计划的人士没有被授权公开谈论该计划，他们警告说，如果审查的某些部分需要更多时间，批准可能会推迟到周一之后。</blockquote> An F.D.A. spokeswoman declined to comment.<blockquote>F.D.A。女发言人拒绝置评。</blockquote> The agency had recently set an unofficial deadline for approval of around Labor Day.<blockquote>该机构最近设定了一个非官方的批准截止日期，大约在劳动节前后。</blockquote> The approval is expected to pave the way for a series of vaccination requirements by public and private organizations who were awaiting final regulatory action before putting in effect mandates. Federal and state health officials are also hoping that an approved vaccine will draw interest from some Americans who have been hesitant to take one that was only authorized for emergency use, a phenomenon suggested by recent polling.<blockquote>该批准预计将为公共和私人组织的一系列疫苗接种要求铺平道路，这些组织正在等待最终的监管行动，然后再实施授权。联邦和州卫生官员也希望获得批准的疫苗能够吸引一些美国人的兴趣，他们一直在犹豫是否要接种仅授权紧急使用的疫苗，最近的民意调查表明了这种现象。</blockquote> Some universities and hospitals are expected to mandate inoculation once a vaccine is fully approved. The Pentagon this month&nbsp;said it planned&nbsp;to make Covid vaccinations mandatory for the country’s 1.3 million active-duty troops “no later” than the middle of next month, or sooner if the F.D.A. acts earlier.<blockquote>一旦疫苗获得完全批准，一些大学和医院预计将强制接种疫苗。五角大楼本月表示，计划 “不迟于 ”下月中旬强制全国 130 万现役军人接种 Covid 疫苗，如果美国食品和药物管理局批准，则更早。早点行动。</blockquote> Once it obtains the approval, Pfizer-BioNTech is planning to quickly ask the F.D.A. to approve a third dose as a booster shot. The Biden administration on Wednesday announced that fully vaccinated adults should prepare to get booster shots eight months after they received their second doses, beginning Sept. 20. Pfizer is expected to finish submitting data that it says shows a third shot is safe and effective next week.<blockquote>一旦获得批准，辉瑞-BioNTech计划迅速向F.D.A。批准第三剂作为加强注射。拜登政府周三宣布，从9月20日开始，完全接种疫苗的成年人应该准备在接种第二剂疫苗八个月后接种加强针。辉瑞公司预计将于下周完成提交数据，该数据显示第三剂疫苗是安全有效的。</blockquote> The F.D.A. last week updated its authorizations of Pfizer-BioNTech’s and Moderna’s vaccines to allow third doses for some immunocompromised people, a decision backed by the Centers for Disease Control and Prevention.<blockquote>F.D.A。上周，辉瑞-BioNTech 和 Moderna 疫苗的授权更新，允许一些免疫功能低下的人接种第三剂疫苗，这一决定得到了美国疾病控制和预防中心的支持。</blockquote> Regulators are still reviewing Moderna’s application for full approval for its coronavirus vaccine, and a decision could come at least several weeks after the one for Pfizer-BioNTech. Moderna is planning to submit its data in support of a booster shot in September.<blockquote>监管机构仍在审查 Moderna 的冠状病毒疫苗全面批准申请，辉瑞-BioNTech 的申请至少可能在几周后做出决定。Moderna 计划提交数据以支持 9 月份的加强注射。</blockquote>","collect":0,"html":"<!DOCTYPE html>\n<html>\n<head>\n<meta http-equiv=\"Content-Type\" content=\"text/html; charset=utf-8\" />\n<meta name=\"viewport\" content=\"width=device-width,initial-scale=1.0,minimum-scale=1.0,maximum-scale=1.0,user-scalable=no\"/>\n<meta name=\"format-detection\" content=\"telephone=no,email=no,address=no\" />\n<title>Pfizer and BioNTech SE shares surged in premarket trading<blockquote>辉瑞和 BioNTech SE 股价在盘前交易中飙升</blockquote></title>\n<style type=\"text/css\">\na,abbr,acronym,address,applet,article,aside,audio,b,big,blockquote,body,canvas,caption,center,cite,code,dd,del,details,dfn,div,dl,dt,\nem,embed,fieldset,figcaption,figure,footer,form,h1,h2,h3,h4,h5,h6,header,hgroup,html,i,iframe,img,ins,kbd,label,legend,li,mark,menu,nav,\nobject,ol,output,p,pre,q,ruby,s,samp,section,small,span,strike,strong,sub,summary,sup,table,tbody,td,tfoot,th,thead,time,tr,tt,u,ul,var,video{ font:inherit;margin:0;padding:0;vertical-align:baseline;border:0 }\nbody{ font-size:16px; line-height:1.5; color:#999; background:transparent; }\n.wrapper{ overflow:hidden;word-break:break-all;padding:10px; }\nh1,h2{ font-weight:normal; line-height:1.35; margin-bottom:.6em; }\nh3,h4,h5,h6{ line-height:1.35; margin-bottom:1em; }\nh1{ font-size:24px; }\nh2{ font-size:20px; }\nh3{ font-size:18px; }\nh4{ font-size:16px; }\nh5{ font-size:14px; }\nh6{ font-size:12px; }\np,ul,ol,blockquote,dl,table{ margin:1.2em 0; }\nul,ol{ margin-left:2em; }\nul{ list-style:disc; }\nol{ list-style:decimal; }\nli,li p{ margin:10px 0;}\nimg{ max-width:100%;display:block;margin:0 auto 1em; }\nblockquote{ color:#B5B2B1; border-left:3px solid #aaa; padding:1em; }\nstrong,b{font-weight:bold;}\nem,i{font-style:italic;}\ntable{ width:100%;border-collapse:collapse;border-spacing:1px;margin:1em 0;font-size:.9em; }\nth,td{ padding:5px;text-align:left;border:1px solid #aaa; }\nth{ font-weight:bold;background:#5d5d5d; }\n.symbol-link{font-weight:bold;}\n/* header{ border-bottom:1px solid #494756; } */\n.title{ margin:0 0 8px;line-height:1.3;color:#ddd; }\n.meta {color:#5e5c6d;font-size:13px;margin:0 0 .5em; }\na{text-decoration:none; color:#2a4b87;}\n.meta .head { display: inline-block; overflow: hidden}\n.head .h-thumb { width: 30px; height: 30px; margin: 0; padding: 0; border-radius: 50%; float: left;}\n.head .h-content { margin: 0; padding: 0 0 0 9px; float: left;}\n.head .h-name {font-size: 13px; color: #eee; margin: 0;}\n.head .h-time {font-size: 12.5px; color: #7E829C; margin: 0;}\n.small {font-size: 12.5px; display: inline-block; transform: scale(0.9); -webkit-transform: scale(0.9); transform-origin: left; -webkit-transform-origin: left;}\n.smaller {font-size: 12.5px; display: inline-block; transform: scale(0.8); -webkit-transform: scale(0.8); transform-origin: left; -webkit-transform-origin: left;}\n.bt-text {font-size: 12px;margin: 1.5em 0 0 0}\n.bt-text p {margin: 0}\n</style>\n</head>\n<body>\n<div class=\"wrapper\">\n<header>\n<h2 class=\"title\">\nPfizer and BioNTech SE shares surged in premarket trading<blockquote>辉瑞和 BioNTech SE 股价在盘前交易中飙升</blockquote>\n</h2>\n<h4 class=\"meta\">\n<a class=\"head\" href=\"https://laohu8.com/wemedia/1079075236\">\n\n<div class=\"h-thumb\" style=\"background-image:url(https://static.tigerbbs.com/8274c5b9d4c2852bfb1c4d6ce16c68ba);background-size:cover;\"></div>\n\n<div class=\"h-content\">\nTiger Newspress \n2021-08-23 16:12\n</div>\n</a>\n</h4>\n</header>\n<article>\nPfizer and BioNTech SE shares surged in premarket trading.The F.D.A. is aiming to give full approval to Pfizer’s Covid vaccine on Monday,according to the New York Times.<blockquote>辉瑞和 BioNTech SE 股价在盘前交易中飙升。F.D.A。据《纽约时报》报道，辉瑞公司的目标是在周一全面批准辉瑞公司的 Covid 疫苗。</blockquote> <img src=\"https://static.tigerbbs.com/7fdc37e9193346a16038693153dd045e\" tg-width=\"362\" tg-height=\"125\" width=\"100%\" height=\"auto\"><blockquote></blockquote> The Food and Drug Administration is pushing to approve Pfizer-BioNTech’s two-dose Covid-19 vaccine on Monday, further expediting an earlier timeline for licensing the shot, according to people familiar with the agency’s planning.<blockquote>据熟悉美国食品和药物管理局计划的人士透露，美国食品和药物管理局正在推动在周一批准辉瑞-BioNTech公司的两剂Covid-19疫苗，进一步加快了疫苗许可的早期时间表。</blockquote> Regulators were working to finish the process by Friday but were still working through a substantial amount of paperwork and negotiation with the company. The people familiar with the planning, who were not authorized to speak publicly about it, cautioned that the approval might slide beyond Monday if some components of the review need more time.<blockquote>监管机构正在努力在周五之前完成这一流程，但仍在与该公司进行大量的文书工作和谈判。熟悉该计划的人士没有被授权公开谈论该计划，他们警告说，如果审查的某些部分需要更多时间，批准可能会推迟到周一之后。</blockquote> An F.D.A. spokeswoman declined to comment.<blockquote>F.D.A。女发言人拒绝置评。</blockquote> The agency had recently set an unofficial deadline for approval of around Labor Day.<blockquote>该机构最近设定了一个非官方的批准截止日期，大约在劳动节前后。</blockquote> The approval is expected to pave the way for a series of vaccination requirements by public and private organizations who were awaiting final regulatory action before putting in effect mandates. Federal and state health officials are also hoping that an approved vaccine will draw interest from some Americans who have been hesitant to take one that was only authorized for emergency use, a phenomenon suggested by recent polling.<blockquote>该批准预计将为公共和私人组织的一系列疫苗接种要求铺平道路，这些组织正在等待最终的监管行动，然后再实施授权。联邦和州卫生官员也希望获得批准的疫苗能够吸引一些美国人的兴趣，他们一直在犹豫是否要接种仅授权紧急使用的疫苗，最近的民意调查表明了这种现象。</blockquote> Some universities and hospitals are expected to mandate inoculation once a vaccine is fully approved. The Pentagon this month&nbsp;said it planned&nbsp;to make Covid vaccinations mandatory for the country’s 1.3 million active-duty troops “no later” than the middle of next month, or sooner if the F.D.A. acts earlier.<blockquote>一旦疫苗获得完全批准，一些大学和医院预计将强制接种疫苗。五角大楼本月表示，计划 “不迟于 ”下月中旬强制全国 130 万现役军人接种 Covid 疫苗，如果美国食品和药物管理局批准，则更早。早点行动。</blockquote> Once it obtains the approval, Pfizer-BioNTech is planning to quickly ask the F.D.A. to approve a third dose as a booster shot. The Biden administration on Wednesday announced that fully vaccinated adults should prepare to get booster shots eight months after they received their second doses, beginning Sept. 20. Pfizer is expected to finish submitting data that it says shows a third shot is safe and effective next week.<blockquote>一旦获得批准，辉瑞-BioNTech计划迅速向F.D.A。批准第三剂作为加强注射。拜登政府周三宣布，从9月20日开始，完全接种疫苗的成年人应该准备在接种第二剂疫苗八个月后接种加强针。辉瑞公司预计将于下周完成提交数据，该数据显示第三剂疫苗是安全有效的。</blockquote> The F.D.A. last week updated its authorizations of Pfizer-BioNTech’s and Moderna’s vaccines to allow third doses for some immunocompromised people, a decision backed by the Centers for Disease Control and Prevention.<blockquote>F.D.A。上周，辉瑞-BioNTech 和 Moderna 疫苗的授权更新，允许一些免疫功能低下的人接种第三剂疫苗，这一决定得到了美国疾病控制和预防中心的支持。</blockquote> Regulators are still reviewing Moderna’s application for full approval for its coronavirus vaccine, and a decision could come at least several weeks after the one for Pfizer-BioNTech. Moderna is planning to submit its data in support of a booster shot in September.<blockquote>监管机构仍在审查 Moderna 的冠状病毒疫苗全面批准申请，辉瑞-BioNTech 的申请至少可能在几周后做出决定。Moderna 计划提交数据以支持 9 月份的加强注射。</blockquote>\n</article>\n</div>\n</body>\n</html>\n","type":0,"thumbnail":"","relate_stocks":{"PFE":"辉瑞","BNTX":"BioNTech SE"},"is_english":true,"share_image_url":"https://static.laohu8.com/e9f99090a1c2ed51c021029395664489","article_id":"1104804215","content_text":"Pfizer and BioNTech SE shares surged in premarket trading.The F.D.A. is aiming to give full approval to Pfizer’s Covid vaccine on Monday,according to the New York Times.\n\nThe Food and Drug Administration is pushing to approve Pfizer-BioNTech’s two-dose Covid-19 vaccine on Monday, further expediting an earlier timeline for licensing the shot, according to people familiar with the agency’s planning.\nRegulators were working to finish the process by Friday but were still working through a substantial amount of paperwork and negotiation with the company. The people familiar with the planning, who were not authorized to speak publicly about it, cautioned that the approval might slide beyond Monday if some components of the review need more time.\nAn F.D.A. spokeswoman declined to comment.\nThe agency had recently set an unofficial deadline for approval of around Labor Day.\nThe approval is expected to pave the way for a series of vaccination requirements by public and private organizations who were awaiting final regulatory action before putting in effect mandates. Federal and state health officials are also hoping that an approved vaccine will draw interest from some Americans who have been hesitant to take one that was only authorized for emergency use, a phenomenon suggested by recent polling.\nSome universities and hospitals are expected to mandate inoculation once a vaccine is fully approved. The Pentagon this month said it planned to make Covid vaccinations mandatory for the country’s 1.3 million active-duty troops “no later” than the middle of next month, or sooner if the F.D.A. acts earlier.\nOnce it obtains the approval, Pfizer-BioNTech is planning to quickly ask the F.D.A. to approve a third dose as a booster shot. The Biden administration on Wednesday announced that fully vaccinated adults should prepare to get booster shots eight months after they received their second doses, beginning Sept. 20. Pfizer is expected to finish submitting data that it says shows a third shot is safe and effective next week.\nThe F.D.A. last week updated its authorizations of Pfizer-BioNTech’s and Moderna’s vaccines to allow third doses for some immunocompromised people, a decision backed by the Centers for Disease Control and Prevention.\nRegulators are still reviewing Moderna’s application for full approval for its coronavirus vaccine, and a decision could come at least several weeks after the one for Pfizer-BioNTech. Moderna is planning to submit its data in support of a booster shot in September.","news_type":1,"symbols_score_info":{"BNTX":0.9,"PFE":0.9}},"isVote":1,"tweetType":1,"viewCount":1121,"commentLimit":10,"likeStatus":false,"favoriteStatus":false,"reportStatus":false,"symbols":[],"verified":2,"subType":0,"readableState":1,"langContent":"EN","currentLanguage":"EN","warmUpFlag":false,"orderFlag":false,"shareable":true,"causeOfNotShareable":"","featuresForAnalytics":[],"commentAndTweetFlag":false,"andRepostAutoSelectedFlag":false,"upFlag":false,"length":8,"subscribersOnly":false,"subscribersOnlyAccessible":false,"xxTargetLangEnum":"ORIG"},"commentList":[],"isCommentEnd":true,"isTiger":false,"isWeiXinMini":false,"url":"/m/post/835635214"}